Second License Period Sample Clauses

Second License Period. STE shall have the exclusive right to exhibit each Picture licensed hereunder for 120 Exhibition Days (in the aggregate) on up to 10 channels of the STE Pay Television Services (for purposes of clarification, SOD services shall not count as channels) during a 13-month period (“Second License Period”) which shall commence between one year and six years and one month after the end of the First License Period. Licensor shall notify STE in writing of the commencement date of the Second License Period at least one hundred fifty (150) days prior to such date. Notwithstanding the foregoing, if Licensor fails to notify STE by two years after the end of the First License Period for a Picture that Licensor has entered into one or more permitted Television license agreements with respect to such Picture, and Licensor fails to so notify STE within 10 days after receipt by Licensor of a notice from STE informing Licensor of such failure, then the Second License Period for such Picture shall commence five months after the date of STE’s notice to Licensor of such failure.
Sample 1Sample 2
AutoNDA by SimpleDocs
Second License Period. STE shall have the exclusive right to exhibit each Picture licensed hereunder for three hundred (300) Exhibitions (in the aggregate) on up to 10 channels of the STE Pay Television Services (for purposes of clarification, SOD services shall not count as channels) (i) for Pictures having an Initial Theatrical Release prior to January 1, 2017, during a 13-month period and (ii) for Pictures having an Initial Theatrical Release on January 1, 2017 or later, a 15-month period (“Second License Period”) which shall commence between one year and six years and one month after the end of the First License Period. Licensor shall notify STE in writing of the commencement date of the Second License Period at least one hundred fifty (150) days prior to such date. Notwithstanding the foregoing, if Licensor fails to notify STE by two years after the end of the First License Period for a Picture that Licensor has entered into one or more permitted Television license agreements with respect to such Picture, and Licensor fails to so notify STE within 10 days after receipt by Licensor of a notice from STE informing Licensor of such failure, then the Second License Period for such Picture shall commence five months after the date of STE’s notice to Licensor of such failure. Window Interruptions. For up to two Pictures per release Year, which Pictures for such release Year shall not be among the top three box office Pictures to be licensed hereunder for such release Year, Licensor may interrupt STE’s First License Period for a single exhibition on any Television service (other than a Pay Television service) in the Territory that Licensor or any Licensor Affiliate operates or manages, provided, that Licensor or such Licensor Affiliate, as applicable, must have an ownership interest in such service, with a corresponding extension of STE’s First License Period. Such interruption shall occur no earlier than the 12th month of the First License Period and shall last no longer than three months within such interruption period. Licensor shall notify STE in writing if a Picture’s First License Period is to be interrupted not later than the end of the sixth month of such Picture’s First License Period. No promotion of such exhibition of such Picture may occur until the interruption period begins. The License Fee for a Picture whose First License Period is interrupted pursuant to this Section 3(c) which is exhibited only in the Spanish language shall be 75% of the License Fee determined pur...
Sample 1

Related to Second License Period

  • License Period The license granted hereunder shall be effective and terminate as of the dates specified in Schedule D attached hereto, unless sooner terminated or renewed in accordance with the terms and conditions hereof.

  • License Term The license term shall commence upon the License Effective Date, provided, however, that where an acceptance or trial period applies to the Product, the License Term shall be extended by the time period for testing, acceptance or trial.

  • Exclusivity Period During the Exclusivity Period each Party shall:

  • End User License Agreement This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. xxxx://xxxxxxxxxxxxxxx.xxx/licenses/by-nc-nd/3.0/ You are free to: Share: to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work).

  • Notice of a License Action Grantee shall notify their contract manager of any action impacting its license to provide services under this Contract within five days of becoming aware of the action and include the following:

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.

  • License Type Your license to a Product will be under a Named User or CPU license type, as specified on an order. Each Named User license to a Product entitles a Named User to access and use that Product in one production environment and up to two non-production environments. Each CPU license to a Product entitles you to assign the Product to a single CPU in one production environment and up to two non-production environments, for use in support of an unspecified number of Named Users.

  • Sublicense Rights Subject to the terms and conditions of this Agreement, Astellas shall have the right to grant sublicenses of the rights granted to it under Section 3.1.1 and 2.5.3(c) through multiple tiers to its Affiliates, provided that Astellas shall be and remain responsible for performance of all its obligations under this Agreement, and any action by an Affiliate shall be deemed an action by Astellas for which it is responsible. Astellas and its Affiliates may grant sublicenses through multiple tiers to Third Parties (a) whose primary business is contract manufacturing, solely for manufacturing and supplying Licensed Compound or Product to Astellas or any Related Party or (b) to a subcontractor to perform Astellas’s assigned responsibilities under this Agreement or any Research Plan, Development Plan or Co-Promotion Plan. All other sublicenses to be granted by Astellas or any Astellas Affiliate in the Joint Development Territory prior to […***…] will require prior written approval from Ambit, which shall not be unreasonably withheld or delayed, provided that in the event such sublicense is to all of Astellas’s rights in the U.S. or the Joint Development Territory to a Person who is not an Astellas Affiliate such approval shall be at Ambit’s sole discretion. In the case of sublicenses pursuant to the immediately preceding sentence above, Astellas shall provide to Ambit, upon Ambit’ written request, a copy of all executed agreements in which rights granted by Ambit under this Agreement are sublicensed (and Astellas shall have the right to make reasonable redactions prior to providing such agreements(s)). Ambit shall treat all such sublicense agreements as Astellas’s Confidential Information. Astellas or its Affiliates may grant sublicenses (i) in the Joint Development Territory at any time after the first NDA Submission in the Joint Development Territory, provided that, with respect to each applicable Product in the U.S., the Required Exercise Date has occurred and Ambit has not exercised the Co-Promotion Option or the Co-Promotion Term has expired or terminated and (ii) outside the Joint Development Territory, in each case ((i) and (ii)) through multiple tiers of Sublicensees without Ambit’s approval. Each sublicense granted by Astellas pursuant to this Section 3.1.2 shall be subject and subordinate to the terms and conditions of this Agreement. Any sublicense granted by Astellas shall impose on the Sublicensee obligations consistent with the terms and conditions of this Agreement, with each Sublicensee being required to comply with the obligations under this Agreement applicable to Sublicensees, and also to comply with the generally-applicable obligations of this Agreement that are appropriate for application to Sublicensees. Astellas shall ensure that all Persons to which it (or its Affiliate) grants sublicenses comply with all applicable terms and conditions of this Agreement, and Astellas shall be responsible for any failure of any such Sublicensee to comply with such terms or conditions, with the further understanding that any action or omission by any such Sublicensee that, if committed by Astellas would be a breach of this Agreement (with respect to those country(ies)) in which such Sublicensee is sublicensed), will be deemed a breach by Astellas of this Agreement (with respect to those country(ies) in which such Sublicensee is sublicensed) for which Astellas is responsible. Without limiting the foregoing, no sublicense shall modify Ambit’s rights or obligations under this Agreement (including Ambit’s Co-Promotion rights). Without limiting the foregoing, any sublicense agreement shall contain the following provisions, as applicable: (i) a requirement that such Sublicensee submit applicable Net Sales or other reports consistent with those required hereunder; (ii) audit requirements similar to those set forth in this Agreement; and (iii) a requirement that such Sublicensee comply with the confidentiality provisions of Article 6 with respect to Ambit’s Confidential Information.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • License Rights The Recipient must provide a license to its “subject data” to the Federal Government, which license is: (a) Royalty-free, (b) Non-exclusive, and (c) Irrevocable, (2) Uses. The Federal Government’s license must permit the Federal Government to take the following actions provided those actions are taken for Federal Government purposes: (a) Reproduce the subject data, (b) Publish the subject data, (c) Otherwise use the subject data, and (d) Permit other entities or individuals to use the subject data, and

Time is Money Join Law Insider Premium to draft better contracts faster.